Lorraine A. Cazenave

1.5k citations
7 papers · 1.3k indexed · 1 hit paper · h-index 6
  • Oncology top 5%
    • Neutropenia and Cancer Infections 2
    • Cancer Treatment and Pharmacology 2
    • Lung Cancer Research Studies 2
    • Drug Transport and Resistance Mechanisms 1
  • Hematology top 10%
  • Cell Biology top 10%
  • Toxicology top 10%
  • Dermatology top 10%
    • Cancer therapeutics and mechanisms 2
    • Genomics, phytochemicals, and oxidative stress 1
    • Glutathione Transferases and Polymorphisms 1
    • Microbial Natural Products and Biosynthesis 1

Lorraine A. Cazenave

7 papers receiving 1.2k citations

Hit Papers

Taxol: A Novel Investigational Antimicrotubule Agent8951990202620022014250500750

Peers

Lorraine A. Cazenave
Comparison fields: 5 of 91
  • Oncology 847
  • Hematology 122
  • Cell Biology 147
  • Toxicology 30
  • Dermatology 73
Replace Marie-Christine Bissery with:
Marie-Christine Bissery France
Leonard Lothstein United States
Donehower Rc United States
Zhirong Zhan United States
Susan Bakke United States
Donald J. Dykes United States
Dorothée Sémiond France
R F Ozols United States
Jun Ho Yi South Korea
Haruhiko Makino Japan
Lorraine A. Cazenave relative to Marie-Christine Bissery France Marie-Christine Bissery's profile →
Citations per field
00.5×2.5×
Marie-Christine Bissery · 1×
Citations per year

Countries citing papers authored by Lorraine A. Cazenave

Since Specialization
Citations

This map shows the geographic impact of Lorraine A. Cazenave's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorraine A. Cazenave with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorraine A. Cazenave more than expected).

Fields of papers citing papers by Lorraine A. Cazenave

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorraine A. Cazenave. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorraine A. Cazenave. The network helps show where Lorraine A. Cazenave may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Lorraine A. Cazenave, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lorraine A. Cazenave Line = papers co-authored together Lorraine A. Cazenave links everyone, so they are left out of the graph.

All Works

7 of 7 papers shown
#Work
1 200066
2 199435
3 19941
4 199381
5 1993119
6
Taxol: A Novel Investigational Antimicrotubule Agentbreakdown →
1990895
7 198981

About Lorraine A. Cazenave

Lorraine A. Cazenave is a scholar working on Oncology, Small Animals, Pharmacology, Cancer Research and Cell Biology, having authored 7 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (2 papers), Neutropenia and Cancer Infections (2 papers), Cancer Treatment and Pharmacology (2 papers), Lung Cancer Research Studies (2 papers), Genomics, phytochemicals, and oxidative stress (1 paper), Microbial Natural Products and Biosynthesis (1 paper), Glutathione Transferases and Polymorphisms (1 paper) and Drug Transport and Resistance Mechanisms (1 paper). The work is most often cited by research in Oncology (847 citations), Hematology (122 citations), Cell Biology (147 citations), Toxicology (30 citations) and Dermatology (73 citations). Lorraine A. Cazenave has collaborated with scholars based in United States and India. Frequent co-authors include Ross C. Donehower, Eric K. Rowinsky, Kenneth H. Cowan, Miloslav Beran, Charles Koller, HM Kantarjian, Leonard A. Zwelling, Amy Ellis, Jeffrey A. Moscow and MJ Keating. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Blood, Cancer treatment and research, JNCI Journal of the National Cancer Institute and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026